Celebrating 33 years of bringing the community together to discuss time-critical antibody engineering updates and best practices. Join leading scientists, engineers, and executives from the leading companies and academic institutions to discuss:    

• Basic science of Antibody Engineering
• Antibody-based drug products in preclinical and clinical development
• Alternative scaffold and next-generation protein therapeutic development
• Novel scaffolds and preclinical/clinical data
• Creative technologies to improve drug-like and biophysical properties of new molecules
• Engineering and design strategies
• Emerging preclinical/clinical data to make better adc's, bispecifics, antibody mixtures and  novel antibody molecules
• Scientific advances in bioprocessing
• Costs of developing and producing antibodies